Drug
89zr Dfo Ys5
89zr Dfo Ys5: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| 89Zr-DFO-YS5 NCT05245006 | Phase 1 | Prostate Cancer |
Latest
No recent events.
Follow 89zr Dfo Ys5 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.